We are live on ! Find out more
CC

Cannell & Co Portfolio holdings

AUM $3.15B
1-Year Est. Return 30.62%
This Fund
S&P 500
This Quarter Est. Return
+4.62%
1 Year Est. Return
+30.62%
3 Year Est. Return
+51.59%
5 Year Est. Return
+187.25%
10 Year Est. Return
+311.51%
AUM
$2.76B
AUM Growth
+$12.4M
Cap. Flow
-$81.1M
Cap. Flow %
-2.93%
Top 10 Hldgs %
27.85%
Holding
271
New
9
Increased
35
Reduced
133
Closed
22

Sector Composition

1 Healthcare 19.22%
2 Technology 15.12%
3 Industrials 12.53%
4 Financials 11.35%
5 Communication Services 8.91%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MJN
226
DELISTED
Mead Johnson Nutrition Company
MJN
$277K 0.01%
3,917
TEVA icon
227
Teva Pharmaceuticals
TEVA
$37.3B
$268K 0.01%
7,384
CVS icon
228
CVS Health
CVS
$136B
$264K 0.01%
3,340
-5,670
-63% -$459K
DL
229
DELISTED
China Distance Education Holdings Limited
DL
$260K 0.01%
23,279
ENLC
230
DELISTED
ENLINK MIDSTREAM, LLC
ENLC
$257K 0.01%
13,500
AES.PRC.CL
231
DELISTED
AES Corporation Class C Preferred
AES.PRC.CL
$252K 0.01%
5,000
LEN icon
232
Lennar Class A
LEN
$20.2B
$250K 0.01%
+6,120
New +$248K
MAT icon
233
Mattel
MAT
$4.17B
$247K 0.01%
8,954
NFLX icon
234
Netflix
NFLX
$291B
$243K 0.01%
19,650
-5,500
-22% -$65.2K
BPL
235
DELISTED
Buckeye Partners, L.P.
BPL
$239K 0.01%
3,614
PGC icon
236
Peapack-Gladstone Financial
PGC
$808M
$231K 0.01%
+7,472
New +$192K
MMP
237
DELISTED
Magellan Midstream Partners, L.P.
MMP
$219K 0.01%
2,900
PCG icon
238
PG&E
PCG
$38.2B
$213K 0.01%
3,500
NSH
239
DELISTED
NuStar GP Holdings LLC
NSH
$211K 0.01%
7,300
-900
-11% -$23.1K
JNS
240
DELISTED
Janus Capital Group Inc
JNS
$183K 0.01%
13,800
-2,475
-15% -$34K
TEUM
241
DELISTED
Pareteum Corporation
TEUM
$180K 0.01%
60,199
GNMK
242
DELISTED
GenMark Diagnostics, Inc
GNMK
$122K ﹤0.01%
10,000
STNG icon
243
Scorpio Tankers
STNG
$3.81B
$109K ﹤0.01%
2,400
+400
+20% +$17.3K
UNXL
244
DELISTED
Uni-Pixel, Inc.
UNXL
$98K ﹤0.01%
100,000
IMBI
245
DELISTED
iMedia Brands, Inc. Class A Common Stock
IMBI
$75K ﹤0.01%
5,000
AVEO
246
DELISTED
AVEO Pharmaceuticals, Inc.
AVEO
$48K ﹤0.01%
8,938
-3,812
-30% -$25.4K
RIBT
247
DELISTED
RiceBran Technologies
RIBT
$44K ﹤0.01%
4,241
KOPN icon
248
Kopin
KOPN
$721M
$31K ﹤0.01%
11,000
VNR
249
DELISTED
Vanguard Natural Resources, LLC
VNR
$8K ﹤0.01%
11,912
AGIO icon
250
Agios Pharmaceuticals
AGIO
$2.35B
-14,700
Closed -$776K

Similar funds

Cannell & Co's Q4 2016 Portfolio in Review

As of Q4 2016, Cannell & Co held 271 positions worth $2.76B, up 0.45% from $2.75B the previous quarter. Its ten largest holdings account for 28% of the portfolio.

Cannell & Co's Q4 2016 filing shows 9 new, 35 increased, 133 reduced and 22 closed positions. Its largest new stake was Noble Midstream Partners LP: 550,575 shares worth $19.8M. The largest sale was Level 3 Communications Inc, an estimated $45.4M.

By sector, the portfolio is most concentrated in Healthcare at 19% of assets, down from 20% a quarter earlier, followed by Technology and Industrials.

  • Cannell & Co's largest Q4 2016 buy was Noble Midstream Partners LP: 550,575 shares worth $19.8M.
  • Cannell & Co added most to Zimmer Biomet in Q4 2016, an estimated $50.6M increase.
  • Cannell & Co's biggest Q4 2016 reduction was Level 3 Communications Inc, cutting an estimated $45.4M.
  • Cannell & Co fully exited EQM Midstream Partners, LP in Q4 2016, selling an estimated $8.72M.
  • Cannell & Co's ten largest holdings make up 28% of its $2.76B portfolio in Q4 2016.
  • Cannell & Co opened 9 new positions and closed 22 in Q4 2016.
  • Cannell & Co's portfolio value rose 0.45% quarter-over-quarter to $2.76B.

Based on Cannell & Co's 13F filing for Q4 2016, filed 13 Feb 2017.